BNB Plus Corp is a biotechnology company executing a yield focused BNB digital asset treasury strategy, while also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Management Team
Stock Information
Shareholder Info – Investor Relations
BNB Plus Corp.
50 Health Sciences Drive
Stony Brook, NY 11790
investor@adnas.com | 631.240.8800
John Ragozzino Jr.
CFA
BnB@icrinc.com
Transfer Agent
Equiniti
6201 15th Ave.
Brooklyn, New York 11219
Tel: 718.921.8210
Fax: 718.921.8355
https://equiniti.com/us/ast-access
For additional information, please click here.
SEC Counsel
Harter Secrest & Emery LLP
1600 Bausch & Lomb Place
Rochester, NY
14604‑2711
260 Madison Avenue, New York, NY 10016
.
BNB Plus Corp. is not able to purchase shares on your behalf, and it is not possible for you to purchase shares directly from us. Please contact a stockbroker, bank, or independent financial advisor, who should be able to act on your behalf.
Auditor
CBIZ
10 Melville Park Road
Melville, NY 11790
tel: 631 414 4000
fax: 631 414 4001
http://www.marcumllp.com
Board of Directors
BNB Plus Corp’s Board of Directors consists of individuals with proven leadership skills, broad management experience in established companies, and their reputation as independent thinkers.
